South Africa: Ownership Of Genetic Information And Tissues Under The South African National Health Act

Last Updated: 19 September 2018
Article by Joanne van Harmelen

Most Read Contributor in South Africa, September 2018

Background

The legal and philosophical aspects relating to the concept of "ownership" with respect to human biological material of various kinds has been hotly debated. This an emotive topic and requires balancing societal and commercial interests and the rights of the individual, including the constitutionally enshrined right to bodily and psychological integrity, which includes the right not to be subjected to medical research or scientific experiments without the individual's informed consent.

Common law

South African common law, based on Roman Dutch origins, provides that the human body is a thing outside the commercial sphere and so cannot be owned. On the other hand, separated biological materials are, at common law, considered res nullius, belonging to no one, until brought under the control of the first person who obtains possession of the separated biological materials. However, the common law can be legislatively superseded.

Statute

In South Africa, the National Health Act, 2003 ("NHA"), particularly chapter 8, together with the relevant regulations, governs the use of human biological materials, including genetic material and research with human participants. Although the NHA provides restrictions around the sampling and use of human biological materials which, inter alia, may not be removed without informed consent, may only be donated to prescribed institutions, and may only be used for restricted purposes, there are no provisions relating to ownership or proprietary rights of human biological materials per se.

Only the regulations relating to the artificial fertilisation of persons deal with ownership. A gamete donated to an authorised institution for artificial fertilisation is first owned by the authorised institution that removed the gamete, and after receipt of the gamete by the authorised institution that will effect artificial fertilisation, the gamete is owned by that institution. Alternatively, a gamete donated for artificial fertilisation of a spouse is owned by the donor spouse prior to artificial fertilisation, and after artificial fertilisation by the recipient spouse.

Altruism versus benefit sharing

It is important to note that the NHA and regulations specifically prohibit any person who has donated human biological material, including genetic material, from receiving any form of financial or other reward for such donation, except for the reimbursement of reasonable costs incurred by him or her to provide such donation. Non-compliance with this provision amounts to an offence, for which a convicted person may be sentenced to a fine or imprisonment for not more than five years, or both. The regulations do provide for potential incentives, or benefits to be provided to donors, including the possible provision of beneficial products or interventions post-research, but this should be carefully managed so as not to be considered a financial or other reward for the donation.

Informed consent relating to future research

The NHA and its regulations on research with human participants provide that it is necessary to obtain prior informed consent from a human participant about whom a researcher obtains data or specimens or identifiable private information through intervention or interaction with that person. This means that the participant must be provided with sufficient information that allows them to understand, inter alia, the nature and purpose of the research and use of their biological materials and they have the right to decide whether or not to consent to such use and to freely withdraw their consent to such use without penalty or reason.

Previously, it was unclear whether or not there was a requirement for additional informed consent to be obtained in respect of subsequent research performed by research institutions that were provided the human biological material from the research institute to whom informed consent had initially been given by the participant. However, in terms of the Material Transfer Agreement of Human Biological Materials (the "MTA"), published on 20 July 2018, informed consent is now required to be obtained by all providing and recipient institutes of human biological materials for use in research or clinical trials under the auspices of the registered Human Research Ethics Committees ("HRECs"). This agreement defines informed consent as a formal agreement that a donor (with legal capacity to do so) signs to give permission for donation of human biological materials and related data, after being informed about the project. This includes an ongoing information sharing process which allows the donor to consent to participate and determine whether and how their biological materials and data will be utilised in heath research projects, as approved by the HREC from time to time.

Clause 10 of the MTA specifically requires that the providing institute must obtain informed consent from the human participant(s) to provide materials to the recipient institute to undertake the project and that should there be secondary use(s) of their materials for research other than that consented to in the originally approved protocol, additional informed consent must be obtained by the providing institute for any such secondary use(s).

Foreign precedent regarding ownership of human biological materials

The question of ownership of human biological materials has never been tested by the South African courts. It is possible that foreign case law may be considered by our courts should there ever be litigation relating to this subject in future, but there is no clear precedent based on foreign case law and so the outcome of any future litigation remains uncertain.

This article was first published on www.internationallawoffice.com.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions